Chronic Kidney Disease (CKD) clinical trials
177 active trials name this condition (recorded in the registry as “Chronic Kidney Disease”) . Describe your situation to see which ones look like a fit.
Refine by biomarker
By location
- A Study to Evaluate the Efficacy and Safety of Veverimer for the Treatment of Metabolic Acidosis
- Safety of Short-course of NSAIDs in Pediatric Patients With CKD
- Adia Med of Winter Park LLC Chronic Kidney Disease Research Study
- Equol and Vascular Function in Women With Chronic Kidney Disease
- Breakthrough - T1DM and Chronic Kidney Disease
- Sit Less, Interact and Move More (SLIMM) 2 Study
- Technology Assisted Collaborative Care Intervention to Improve Patient-centered Outcomes in Dialysis Patients
- Staged Kidney Transplantation During Combined Heart/Kidney Transplantation
- Inspiratory Muscle Strength Training in Chronic Kidney Disease
- A Study to Evaluate the Safety (Compared to Iron Sucrose), Efficacy and Pharmacokinetics of Ferumoxytol for the Treatment of Iron Deficiency Anemia (IDA) in Pediatric Subjects With Chronic Kidney Disease (CKD)
- Transcutaneous Auricular Vagus Nerve Stimulation (taVNS) in Chronic Kidney Disease (CKD)
- Study to Evaluate the Effect of Balcinrenone/Dapagliflozin in Patients With Heart Failure and Impaired Kidney Function
- Oral Iron in Children With Chronic Kidney Disease
- Mindfulness in Chronic Kidney Disease
- A Randomized Controlled Trial of Thyroid Hormone Supplementation in Hemodialysis Patients
- Concomitant Renal and Urinary Bladder Allograft Transplantation
- Risk of Acute Complications With Rocuronium vs Cisatracurium in Patients With Chronic Kidney Disease
- EASi-KIDNEY™ (The Studies of Heart & Kidney Protection With BI 690517 in Combination With Empagliflozin)
- A Study to Learn More About How Well the Study Treatment Finerenone Works, How Safe it is, How it Moves Into, Through, and Out of the Body, and the Effects it Has on the Body When Taken With an ACE Inhibitor or Angiotensin Receptor Blocker in Children With Chronic Kidney Disease and Proteinuria
- A Study to Learn More About How Safe the Study Treatment Finerenone is in Long-term Use When Taken With an ACE Inhibitor or Angiotensin Receptor Blocker Over 18 Months of Use in Children and Young Adults From 1 to 18 Years of Age With Chronic Kidney Disease and Proteinuria
- Proact: A Study of REACT in Subjects With Type 2 Diabetes Mellitus and Chronic Kidney Disease
- Ferric Citrate and Chronic Kidney Disease in Children
- A Study of a Novel Iron-based Phosphate Binder AP301 in Patients With Hyperphosphatemia in the U.S. and China
- A Phase III Renal Outcomes and Cardiovascular Mortality Study to Investigate the Efficacy and Safety of Baxdrostat in Combination With Dapagliflozin in Participants With Chronic Kidney Disease and High Blood Pressure
- A Phase IIb Study to Evaluate the Effect of Dapagliflozin in Combination With Baxdrostat Compared With Baxdrostat on Albuminuria in Participants With Chronic Kidney Disease and High Blood Pressure.
- Acute Equol Supplementation and Vascular Function in Women With and Without CKD
- Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of OJR520 in Healthy Volunteers and Participants With Chronic Kidney Disease
- Exercise and Monitoring With Post-Hospitalization Muscle Atrophy to Sustain Intrinsic Capacity and Strength
- Physical Activity in CKD
- A Study Comparing the Clinical Benefit of Finerenone Versus a Fixed Dose Combination (FDC) of Extended-Release Torsemide and Spironolactone in Patients With Hypertension and Chronic Kidney Disease
- Effects of Replacing High Protein Foods in People With Chronic Kidney Disease
- Transcutaneous Auricular Vagus Nerve Stimulation Device in CKD Population
- Anti-Inflammatory Treatment of Uremic Cardiomyopathy With Colchicine
- A Study to Investigate the Safety, Tolerability, and Preliminary Efficacy With AION-301 Administered by Intravenous Infusion Compared With Placebo Administered by Intravenous Infusion Investigational Intervention in Participants Aged 35 to 75 Years of Age With Chronic Kidney Disease (CKD)
- Outcomes of Physiologic Insulin Resensitization (PIR) in Patients With Chronic Kidney Disease and Type 2 Diabetes Mellitus
- A Study to Find Out How EMPAgliflozin is Tolerated and if it Helps Children and Adolescents With Chronic KIDNEY Disease (EMPA-KIDNEY® Kids)
- Feasibility Trial of Sodium-GLucose coTransporter 2 INhibitors in Pediatric Chronic KIDney DiSease
- Accelerated Age-related Cognitive Decline: Impact of Exercise on Executive Function and Neuroplasticity
- Patient-driven Management of BP in CKD
- Effect of Empagliflozin on Podocyte Specific Proteins in African American Veterans With NDKD
- Effects of Combination Exercise on Fatigability in Veterans With Chronic Kidney Disease
- A Research Study Comparing How Well Different Doses of the Medicine NNC0519-0130 Can Reduce Kidney Damage in People Living With Chronic Kidney Disease
- A Trial of Etelcalcetide in Pediatric Participants With Secondary Hyperparathyroidism and Chronic Kidney Disease on Hemodialysis
- Testosterone Treatment in Men with Chronic Kidney Disease
- Pivotal Study of the Velocity™ pAVF System
- A Study to Evaluate Safety, Tolerability and Efficacy of AP306 at Fixed Doses in Dialysis Participants With Hyperphosphatemia
- Empagliflozin Treatment in Kidney Transplant Recipients
- Study to Assess the Effects of Angiopoietin-like Protein 3 (ANGPTL3) Inhibition in Adult Participants With Diabetic Kidney Disease
- SAVE-FistulaS: the SelfWrap-Assisted ArterioVEnous Fistulas Study
- Combination of Novel Therapies for CKD Comorbid Depression
Guides for people searching for a trial
- Why people get turned down — and what to do nextWhat eligibility criteria are for, what keeps people out, and where to go when the first door closes.
- How your biomarkers decide which trials you qualify forEGFR, HER2, BRAF, PD-L1 and the rest — what they are and why they increasingly gate access.
- How to search for a trial without losing your mindWhere to look, what to gather first, and how to read what you find.
- What Phase 1, 2 and 3 actually mean for youWhat each phase is testing, and how to weigh an early-phase trial against a later one.
- 10 questions to ask before you say yesTreatment, time, cost, safety and your rights. Worth bringing to a screening visit.
- You matched with a trial. What happens now?Phone screens, the screening visit, informed consent, and day one.
Showing active trials that list “Chronic Kidney Disease” as a condition. Eligibility shown on each trial is an estimate — the trial's study team makes the final decision.